Cancer care & immunotherapy

Personalized immune-based approaches in cancer care.

The immune system plays an important role in recognizing and responding to abnormal cells. Modern cancer immunotherapy seeks to harness or modify immune responses as part of cancer treatment.

Important. Cancer treatment decisions should always be made with a qualified oncology team. The information below is educational. We provide supportive and integrative care alongside — not in place of — your clinical treatment.
Recognized categories

Clinical immunotherapy

These are established or emerging medical categories of immune-directed cancer treatment, delivered in appropriate clinical settings.

Immune checkpoint inhibitors

Therapies that release natural "brakes" on immune cells so they can respond to tumours.

Monoclonal antibodies

Engineered antibodies designed to target specific markers on cancer cells.

Cellular therapies

Approaches such as adoptive cell therapies that modify or expand immune cells.

Cancer vaccines

Immune-directed strategies intended to prompt a response against tumour-associated targets.

Other immune-directed approaches

Additional established modalities used within oncology practice.

Emerging immune technologies

Newer immune-based methods progressing through research and clinical evaluation.

Alongside your treatment

Integrative cancer support

Cancer care can affect nutrition, sleep, energy, cognitive function, emotional wellbeing and overall quality of life. Integrative supportive care seeks to address these needs alongside treatment provided by your oncology team.

  • Nutritional support during and after treatment
  • Sleep, fatigue and stress management
  • Cognitive and emotional wellbeing
  • Coordination and communication with your medical team
Supportive-care / consultation
Our research & programs

Where our work sits — clearly labelled

We separate our own therapies, products and research from established clinical treatment, and we state the evidence level for each. Placeholders below are for you to complete with accurate, authorised descriptions.

Investigational

TODO: Program / therapy name

TODO: Describe the approach and its current status. Use language such as "being investigated" or "under evaluation" where that reflects the evidence.

Preclinical / laboratory

TODO: Research area

TODO: Describe laboratory or preclinical research, potential mechanisms, and collaborations — without implying established clinical benefit.

Evidence labels: Preclinical Clinical trial Approved clinical use Investigational — use the one that accurately reflects each specific claim.

Talk to us about cancer support.

A consultation can help you understand supportive and integrative options alongside your treatment.